Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

555 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Triple-negative breast cancer.
Foulkes WD, Smith IE, Reis-Filho JS. Foulkes WD, et al. N Engl J Med. 2010 Nov 11;363(20):1938-48. doi: 10.1056/NEJMra1001389. N Engl J Med. 2010. PMID: 21067385 Review.
Genetic screening for breast cancer.
Rosenblatt DS, Foulkes WD, Narod SA. Rosenblatt DS, et al. Among authors: foulkes wd. N Engl J Med. 1996 May 2;334(18):1200-1. doi: 10.1056/NEJM199605023341815. N Engl J Med. 1996. PMID: 8602200 No abstract available.
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
Phelan CM, Lancaster JM, Tonin P, Gumbs C, Cochran C, Carter R, Ghadirian P, Perret C, Moslehi R, Dion F, Faucher MC, Dole K, Karimi S, Foulkes W, Lounis H, Warner E, Goss P, Anderson D, Larsson C, Narod SA, Futreal PA. Phelan CM, et al. Nat Genet. 1996 May;13(1):120-2. doi: 10.1038/ng0596-120. Nat Genet. 1996. PMID: 8673090
Hereditary breast and ovarian cancer: epidemiology, genetics, screening and predictive testing.
Foulkes WD, Narod SA. Foulkes WD, et al. Clin Invest Med. 1995 Dec;18(6):473-83. Clin Invest Med. 1995. PMID: 8714791 Review.
Increased incidence of cancer in first degree relatives of women with double primary carcinomas of the breast and colon.
Foulkes WD, Bolduc N, Lambert D, Ginsburg O, Olien L, Yandell DW, Tonin PN, Narod SA. Foulkes WD, et al. J Med Genet. 1996 Jul;33(7):534-9. doi: 10.1136/jmg.33.7.534. J Med Genet. 1996. PMID: 8818936 Free PMC article.
Screening for cancer in high-risk families.
Foulkes WD, Narod SA. Foulkes WD, et al. Cancer Treat Res. 1996;86:165-82. doi: 10.1007/978-1-4613-1265-9_12. Cancer Treat Res. 1996. PMID: 8886445 Review. No abstract available.
Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.
Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK, Daly M, Wagner-Costalos J, Berman D, Grana G, Fox E, Kane MF, Kolodner RD, Krainer M, Haber DA, Struewing JP, Warner E, Rosen B, Lerman C, Peshkin B, Norton L, Serova O, Foulkes WD, Garber JE, et al. Tonin P, et al. Among authors: foulkes wd. Nat Med. 1996 Nov;2(11):1179-83. doi: 10.1038/nm1196-1179. Nat Med. 1996. PMID: 8898735 Review. No abstract available.
BRCA1 mutations and survival in women with ovarian cancer.
Brunet JS, Narod SA, Tonin P, Foulkes WD. Brunet JS, et al. Among authors: foulkes wd. N Engl J Med. 1997 Apr 24;336(17):1256; author reply 1256-7. N Engl J Med. 1997. PMID: 9121524 No abstract available.
The CDKN2A (p16) gene and human cancer.
Foulkes WD, Flanders TY, Pollock PM, Hayward NK. Foulkes WD, et al. Mol Med. 1997 Jan;3(1):5-20. Mol Med. 1997. PMID: 9132280 Free PMC article. Review.
Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women.
Karp SE, Tonin PN, B├ęgin LR, Martinez JJ, Zhang JC, Pollak MN, Foulkes WD. Karp SE, et al. Among authors: foulkes wd. Cancer. 1997 Aug 1;80(3):435-41. doi: 10.1002/(sici)1097-0142(19970801)80:3<435::aid-cncr11>;2-y. Cancer. 1997. PMID: 9241077
555 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page